BCL2L1 and glioblastoma: Based on these data, we used shRNAs targeting BCL2, Bcl-xL, and MCL-1 anti-apoptotic proteins in stably P21-overexpressing senescent glioblastoma cells, as compared to naïve cells or cells deficient in P21.